Nagor Limited

Nagor Limited manufactures a broad range of medical devices, including surgical instruments, diagnostic tools, and implantable devices. Their portfolio also covers reusable and single-use items for surgical procedures, patient monitoring equipment, imaging assistance devices, and sterile disposables for clinical use. This diversity allows them to serve various medical specialties and procedural needs.

Nagor Limited is based in the United Kingdom, which places its devices under the scope of EU Medical Device Regulation (MDR) requirements. Since the UK is part of the European Economic Area, the company must comply with EU regulatory standards, including registration in the euDAMED database—a centralised EU system for tracking medical devices. This ensures transparency and traceability for authorities and healthcare providers.

Nagor Limited’s devices are listed in the euDAMED database, the official EU registry for medical devices. This registry is critical because it provides authorised bodies, healthcare professionals, and patients with verified information about the devices’ classification, manufacturer details, and compliance status under EU regulations. Listing in euDAMED ensures transparency and helps streamline market surveillance and post-market monitoring.

Nagor Limited’s devices are classified as Class III (high-risk), Class IIa (moderate-risk), and Class IIb (moderate-to-high-risk) under EU regulations. This classification determines the level of scrutiny and regulatory requirements they must meet. For example, Class III devices—such as implants or life-support systems—require rigorous clinical evidence, strict manufacturing controls, and post-market surveillance due to their higher risk to patient safety. Class IIa and IIb devices also undergo thorough evaluation but with slightly less stringent criteria than Class III.

Healthcare providers and regulators check euDAMED listings to verify the legitimacy, classification, and compliance status of Nagor Limited’s devices. Since the registry contains authorised data, it helps confirm whether a device meets EU safety and performance standards before use. For regulators, it aids in market surveillance to ensure devices remain compliant post-market. For clinicians, it provides assurance that the device has undergone proper evaluation and is traceable, reducing risks in patient care.